B

ACCE-researched
Barrick Mining Corporation Common Shares
Basic Materials · Gold · NYSE · United States
$42.43-2.86%
Market cap $69.8BNext earnings 2026-08-10Updated Sep 14, 2026
FAIR VALUE · 6-MODEL CONSENSUS
$42.43+0.0%
confidence-weighted across 6 models
Now $42.43
$42.43
$30.95$67.18
HoldSilver75
See plans
Free accounts get 3 full stock pages a month, including FAIR VALUE · 6-MODEL CONSENSUS.
Unlock the ACCE read
See plans
Free accounts get 3 full stock pages a month, including the ACCE read.

ACCE thesis

Barrick operates five Tier One gold mines producing over 4 million ounces annually, with the Nevada Gold Mines joint venture accounting for 40% of output. The company controls some of the world's lowest-cost, longest-life gold assets including Cortez and Carlin, giving it structural cost advantages over peers who rely on shorter-life, higher-cost deposits. Management just guided 2024 production toward the upper end of 4.1-4.6 million ounces while maintaining all-in sustaining costs below $1,350 per ounce. With gold trading above $2,000 and free cash flow generation of $2.8 billion over the trailing twelve months, Barrick trades at just 6.2x enterprise value to EBITDA versus the sector average of 8.5x. The dividend yield sits at 2.1% with $1.2 billion in net cash providing flexibility for both shareholder returns and growth investment.

Investor warnings · 2 flags
  • high
    Momentum score collapse
    ACCE score dropped 8 points in 90 days (91→83), driven by Momentum sub-score of only 46/100, signalling deteriorating price trend.
  • moderate
    Sequential revenue deceleration
    QoQ revenue growth is -13.0%, contrasting sharply with the strong YoY +66.7%, suggesting recent quarter momentum is fading.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

See pricing

Price

+46.2% · 1Y

Snapshot

Growth100Value84Quality96Momentum77Total89
Valuation
Trailing P/E
11.0x
Forward P/E
9.7x
PEG
0.20
P/B
2.63x
EV / Revenue
3.4x
Book value/sh
$16.59
Enterprise value
$70.7B
Profitability
ROE
27.0%
FCF yield
5.83%
ROIC
12.9%
Health and risk
Debt / equity
0.19
Dividend yield
1.49%
Beta
1.15